Leveraged and inverse ETFs have a surge in popularity in recent years, as risk hungry investors embraced these vehicles as a means of achieving a number of different investment goals. But Rydex, one of the earliest ETF issuers to offer these products, has largely missed out on this boom. The Rockville, Maryland-based firm announced last [...] Related Stories: ETF Exclusive: Guggenheim Partners Buys Rydex ProShares Launches 2x Leveraged, Inverse Biotech ETFs (BIB, BIS) UBS Bans Leveraged, Inverse ETFs